To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
406 Current news of Bayerrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
Outlook for 2022 confirmed – confident about the full year despite uncertainty due to global crises
The Bayer Group had a very successful start to 2022. “We achieved outstanding sales and earnings growth, with particularly substantial gains for our agriculture business,” said Werner Baumann, Chairman of the Board of Management, on Tuesday as he presented the quarterly statement for the first ...
Bayer and Cinven have entered into a definitive agreement regarding the sale of Bayer’s Environmental Science Professional business for a purchase price of 2.6 billion U.S. dollars (2.4 billion euros), Bayer announced on Thursday. “This divestment represents a very attractive purchase price and ...
Group sales increase by 8.9 percent (Fx & portfolio adj.) to 44.081 billion euros
The Bayer Group had a successful year in 2021, both operationally and strategically. “We posted substantial growth, strengthened our innovation pipeline and made progress toward our sustainability targets. All this shows that Bayer is on the right track!” said Werner Baumann, Chairman of the ...
Group sales rise by 14.3 percent (Fx & portfolio adj.) to 9.781 billion euros
The Bayer Group registered a significant increase in sales and earnings in the third quarter of 2021. “We delivered strong operational performance, with all divisions showing strong growth momentum,” said Werner Baumann, Chairman of the Board of Management, on Tuesday when presenting the ...
Net income advances by 40.3 percent to 2.089 billion euros
The Bayer Group had a successful start to 2021. “We’re seeing a good operational performance overall, but we were impacted by negative currency effects as expected,” said CEO Werner Baumann when the quarterly statement for the first quarter of 2021 was published on Wednesday. “Our Crop Science ...
Stable operational development in fiscal 2020 despite the COVID-19 pandemic
In 2020 the Bayer Group weathered the COVID-19 pandemic well from an operational point of view. “That shows very clearly that we are active in the right industries. After all, few things are more important to people than health and nutrition,” said Werner Baumann, Chairman of the Board of ...
Foundation laid for future growth
The Bayer Group delivered robust operational performance in 2020. “Our operational strength in these turbulent times shows just how resilient our businesses are, even during the pandemic,” said Werner Baumann, Chairman of the Board of Management, on Thursday during the company’s Financial News ...
Group sales decrease by 5.1 percent (Fx & portfolio adj.) to 8.506 billion euros
Bayer has confirmed its targets for full-year 2020 following a challenging third quarter due to seasonal factors. “Despite the weak quarter and the substantial impact of the pandemic, our currency- and portfolio-adjusted sales and core earnings per share in the first nine months of the year were ...
Contract until the end of April 2024
The Supervisory Board of Bayer AG has unanimously decided to extend the contract of Werner Baumann, Chairman of the Board of Management, until April 30, 2024. Before the extension, Baumann’s contract would have expired at the 2021 Annual Stockholders’ Meeting. Baumann, 57, has worked for Bayer ...
Ensuring employee safety and maintaining supply chains remain top priorities
The Bayer Group’s businesses turned in a solid performance in the second quarter of 2020 despite the COVID-19 pandemic and the associated uncertainties. “Thanks to the growth in our agricultural business, we raised EBITDA before special items – and we did so in a challenging environment,” said ...